Medical Laboratory Testing and Analysis Services (FSS-621-II)

Ended Master GSA Schedule Awarded

Federal agency
Awardees
57 across 66 IDV awards
Task orders
5,604
Obligated
$1,291,244,349

Vehicle facts

Opportunity
  • 621II, 797FSS040001R2 Solicitation numbers
Agency
Combined task order value
  • $1,339,700,157 Current, with exercised options
  • $1,592,086,497 Potential, with all options
Last date to order 100% complete

IDV award and task order details come from SAM.gov/FPDS.

About this vehicle

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 established this Master GSA Schedule for medical laboratory testing and analysis services on October 1, 2005, with ordering closed as of September 25, 2023. The vehicle is no longer active; the ordering period has expired nearly three years ago, though task orders awarded under it continue to execute.

The schedule contracts clinical laboratory services across 15 subcategories including clinical chemistry, hematology, cytology, anatomic pathology, immunology, hemostasis, endocrinology, cytogenetics, microbiology, serology, pharmacogenetics, urinalysis, and clinical drugs of abuse testing, along with disease-oriented panels and introduction of new product testing. Recent task orders show the vehicle funding both routine laboratory testing for federal facilities and specialized reference laboratory services, including oncology testing (Oncotype DX), genomic sequencing, lung cancer screening, and prostate cancer diagnostics.

Quest Diagnostics Incorporated dominates the vehicle with 3,112 task orders worth $750.1 million in combined potential value. Laboratory Corporation of America holds 855 orders totaling $525.8 million. These two firms account for roughly 81% of all task orders and 85% of the vehicle's $1.57 billion combined potential value. Arup Laboratories, Sonora Quest Laboratories, and Quest Diagnostics Clinical Laboratories fill secondary positions; 27 distinct primes were awarded across 5,447 total task orders. Competitive concentration is high—the top five primes hold 96% of combined potential value.

The vehicle serves 167 distinct federal customer agencies. The Department of Health and Human Services Indian Health Service, Department of Veterans Affairs regional service networks (particularly VISN 21, 17, 10, and 22), and the Bureau of Prisons drive the largest order volumes. Nearly 91% of awarded task orders carry no set-aside designation; small business awards represent less than one percent of orders.

The vehicle shows sustained recent ordering activity despite the closed ordering period. Task orders awarded in 2026 include routine monthly laboratory testing calls in the $2,000 to $50,000 range and mega-orders for specialized reference laboratory services exceeding $2.5 million. Combined task-order dollars obligated stand at $1.27 billion, representing 81% of combined potential value. The 5,447-order portfolio obligates substantial value across federal healthcare and correctional systems, with performance periods extending through 2027 and beyond.

Description

GeneSight Psychotropic Testing

IDV awards

Awardee IDV award Awarded
Mdxhealth, Inc. 36F79727D0004 Anatomic Pathology
Cleveland Diagnostics, Inc. 36F79726D0178 Anatomic Pathology
Luciddx Labs, Inc. 36F79726D0057 621INP
Caris Mpi, Inc. 36F79725D0152 Anatomic Pathology, Pharmacogenetics/Pharmacogenomics and 1 more
Genomind Inc. 36F79725D0144 621INP
Interpath Laboratory, Inc. 36F79725D0013 Anatomic Pathology, Clinical Chemistry and 13 more
Otogenetics Corporation 36F79725D0064 621INP
Southwest Regional Pcr, L.L.C. 36F79725D0014 Microbiology
Precision Pathology Laboratory Services, LLC 36F79725D0005 Immunology
NEO Services LLC 36F79724D0148 Clinical Chemistry, Hematology and 3 more
Millennium Health LLC 36F79724D0051 Clinical Drugs of Abuse and Toxicology
Luxor Scientific LLC 36F79724D0025 Microbiology, Endocrinology and 8 more
Ethos Holding Corp. 36F79724D0009 Clinical Drugs of Abuse and Toxicology, Microbiology and 3 more
Mindera Corp 36F79723D0205 621INP
MCI Diagnostic Center LLC 36F79723D0014 Organ or Disease Oriented Panels, Hematology and 9 more
Biodesix, Inc. 36F79723D0005 Immunology
Aegis Sciences Corporation 36F79722D0052 Microbiology
Central TOX LLC 36F79722D0028 Cytology, Endocrinology and 9 more
Sonora Quest Laboratories LLC 36F79721D0224 Clinical Chemistry, Microbiology and 7 more
Castle Biosciences, Inc. 36F79721D0222 Anatomic Pathology
North Shore Medical Labs Inc. 36F79721D0144 Microbiology, Endocrinology and 10 more
Renalytix AI, Inc. 36F79721D0148 Introduction of New Product Testing
American Molecular Laboratories Inc. 36F79721D0135 Microbiology, Clinical Chemistry
CDX Diagnostics, Inc. 36F79721D0050 Anatomic Pathology
Sonora Quest Laboratories LLC 36F79721D0049 Cytology, Clinical Chemistry and 2 more
Veracyte Labs SD Corporation 36F79721D0019 Anatomic Pathology
Admera Health LLC 36F79721D0011 Organ or Disease Oriented Panels
Guardant Health, Inc. 36F79720D0187 Anatomic Pathology
Pediatric Allergy Solutions LLC 36F79720D0215 Microbiology
Arup Laboratories Inc. 36F79720D0079 Hemostasis, Organ or Disease Oriented Panels and 11 more
Exosome Diagnostics Inc. 36F79720D0097 Anatomic Pathology
Cquentia Ngs, LLC 36F79720D0031 Microbiology, Pharmacogenetics/Pharmacogenomics
Arup Laboratories Inc. 36F79719D0255 Anatomic Pathology, Clinical Drugs of Abuse and Toxicology and 11 more
American Institute Of Toxicology, Inc. 36F79719D0183 Clinical Drugs of Abuse and Toxicology
PTC Laboratories, Inc. 36F79718D0583 Pharmacogenetics/Pharmacogenomics
Allermetrix Inc. 36F79718D0550 Immunology
Veracyte, Inc. 36F79718D0524 Anatomic Pathology, Endocrinology
Fulgent Therapeutics LLC 36F79718D0374 Microbiology, Pharmacogenetics/Pharmacogenomics
Quest Diagnostics Incorporated V797D70090 Endocrinology, Cytology and 13 more
Mdxhealth, Inc. V797D70066 Pharmacogenetics/Pharmacogenomics, Anatomic Pathology and 1 more
Exact Sciences Corporation V797D70053 Pharmacogenetics/Pharmacogenomics, Anatomic Pathology
Aegis Sciences Corporation V797D70054 Clinical Drugs of Abuse and Toxicology
Carenexa, LLC V797D70048 Microbiology, Pharmacogenetics/Pharmacogenomics and 1 more
Pacific Edge Diagnostics USA LTD V797D60660 Introduction of New Product Testing
Helomics Corporation V797D50604 Anatomic Pathology
Cardiodx, Inc. V797D50571 Clinical Chemistry
Genetic Solutions LLC V797D50565 Introduction of New Product Testing
Genomind Inc. V797D50535 Introduction of New Product Testing
Sequenom Center For Molecular Medicine, LLC V797D50539 Clinical Chemistry
Laboratory Corporation Of America V797D50532 Anatomic Pathology, Serology and 13 more
Show 40 more

Latest 50 of 66 listed here. See the rest on GovTribe.

Latest task orders

Task order Awardee Awarding agency Obligated Last action
FCI bennettsville lab testing inmates 15B31727F00000021 Laboratory Corporation Of America FCI $2,465
Viral load testing & SAR COV2 naat tests 15B21626F00000024 Laboratory Corporation Of America FCI $9,050
Laboratory testing FY26 15B50726F00000069 Laboratory Corporation Of America FCI $5,992
FY26 B1 lab corp QTR 4 15B40126F00000148 Laboratory Corporation Of America MCC $1,929
Outside lab testing 15B10926F00000071 Quest Diagnostics Incorporated FMC $19,375
Outside laboratory services 15B30826F00000083 Laboratory Corporation Of America FCI $14,218
Labcorp - FY26 15B61026F00000135 Laboratory Corporation Of America MCC $3,486
Laboratory testing 15BBR026F00000059 Laboratory Corporation Of America MDC $13,126
Dicipher protstate testing 36C25727N0104 Veracyte Labs SD Corporation VISN-17 $48,609
Laboratory testing services for FCI otisville. 15B21126F00000151 Laboratory Corporation Of America FCI $12,478
Laboratory services for inmate population at FCI LA tuna FY2027 15B51027F00000009 Laboratory Corporation Of America FCI $10,000
FY27 labcorp laboratory services OCT-DEC services to be supplied in… 15B61127F00000009 Laboratory Corporation Of America FDC $5,000
National laboratory testing services for various institutions. 15B61826F00000027 Laboratory Corporation Of America USP $12,948
Oncotype DX prostate testing 36C25725N0245 Mdxhealth, Inc. VISN-17 $146,875
Contractor shall provide laboratory testing services to elko service unit . 75H71222F80111 Quest Diagnostics Incorporated IHS $105,630
FCI three rivers FY27 laboratory testing services against FSS number V797D-50532 15B51627F00000012 Laboratory Corporation Of America FCI $6,000
FY27 B1 labcorp laboratory testing annual 27-0030 15B41127F00000032 Laboratory Corporation Of America FCI $13,953
FY27 labcorp labs QTR 1 15B40927F00000013 Laboratory Corporation Of America USP $5,000
FCI fairton: laboratory testing services provided by laboratory corporation… 15B20427F00000001 Laboratory Corporation Of America FCI $4,500
Labcorp services 15B61926F00000121 Laboratory Corporation Of America FCI $3,021
FY26 B1 lab corp labs Q4 15B40226F00000085 Laboratory Corporation Of America FPC $2,063
FCI schuylkill FY26 labcorp labratory services - base period 15B21326F00000053 Laboratory Corporation Of America FCI $3,134
Laboratory testing for USP LEE 15B11726F00000056 Laboratory Corporation Of America USP $7,722
Reference laboratory testing option extension funding 36C25926N0071 Laboratory Corporation Of America VISN-19 $6,396,200
STX nodify lung cancer screening services 36C25726N0025 Biodesix, Inc. VISN-17 $15,764
Show 15 more

Latest 25 of 5,604 listed here. See the rest on GovTribe.

Pools and SINs

Pool or SIN IDV awards
Anatomic Pathology Services for anatomic pathology include, but are not limited to, surgical pathology, molecular pathology, cytopathology, histology, histochemistry, hematopathology, diagnostic electron microscopy… 29
Clinical Drugs of Abuse and Toxicology Services for clinical drugs of abuse and toxicology include, but are not limited to, therapeutic drug monitoring, medical drug of abuse testing, comprehensive drug and poison analyses, and specialized… 25
Microbiology Services for microbiology include, but are not limited to, bacteriology (aerobic and anaerobic), antimicrobial susceptibility testing, molecular infectious disease testing, mycobacteriology, mycology,… 25
Clinical Chemistry Services for clinical chemistry include, but are not limited to, sugar (glucose), electrolytes (sodium, potassium, chloride and carbon dioxide), enzymes (CK, LD, AST, ALT), cholesterol, urea nitrogen,… 22
Immunology Services for immunology include, but are not limited to, adult and pediatric immunodeficiency testing, neutrophil function testing, complement analysis, immunoglobulin and antibody… 20
Endocrinology Services for endocrinology include, but are not limited to, pediatric and adult functional testing, adrenal cortical, water metabolism, pituitary secretion, gonad responsiveness, thyroid, pancreas,… 16
Hematology Services for hematology include, but are not limited to, complete blood count, red blood count, white blood count, differential count, platelet count, coagulation (clotting) studies and hemoglobin.… 15
Organ or Disease Oriented Panels Services for organ or disease oriented panels include, but are not limited to, basic metabolic panel, electrolyte panel, comprehensive metabolic panel, lipid panel, renal function panel, arthritis… 15
Serology Services for serology include, but are not limited to, serologic diagnosis (including bacterial, viral, mycoplasma, and parasitic infections), autoimmune testing, congenital diagnostics testing and… 15
Cytology Services for cytology include, but are not limited to, Papanicolaou smear test (pap screen), nongynelogical body specimens (urine, sputa, body fluids, thoracentesis, paracentesis, cerebrospinal fluid,… 14
Pharmacogenetics/Pharmacogenomics Services for pharmacogenetic/pharmacogenomic testing include, but are not limited to, tests which predict a drug's efficacy or toxicity based upon a patient's genetic makeup. CPT codes include, but… 14
Urinalysis Services for urinalysis include, but are not limited to, urine dipstick chemistry and urine microscopy. CPT Codes include, but are not limited to, 81000-81099. 13
Hemostasis Services for hemostasis include, but are not limited to, comprehensive testing for thrombotic and bleeding disorders; plasminogen, antithrombin, and fibrinogen; protein C, protein S, and APC… 12
Cytogentics Services for cytogenetics include, but are not limited to, amniotic fluid and chorionic villus sampling for prenatal chromosome analysis; peripheral blood from patients with congenital anomalies,… 10
621INP 8
Introduction of New Product Testing A new or improved service that has the potential to provide more economical or efficient means for Federal Agencies to accomplish their mission. Includes test and other products not identified by… 7
Show all 16

Top awardees by obligations

Rank Awardee Obligated Share
1 Quest Diagnostics Incorporated $648,950,950 50%
2 Laboratory Corporation Of America $399,933,132 31%
3 Arup Laboratories Inc. $101,194,499 8%
4 Sonora Quest Laboratories LLC $55,466,562 4%
5 Quest Diagnostics Clinical Laboratories, Inc. $41,603,519 3%
6 Exact Sciences Corporation $15,564,239 1%
7 Quest Diagnostics TB LLC $5,784,418 <1%
8 Veracyte Labs SD Corporation $5,582,209 <1%
9 Mdxhealth, Inc. $2,602,427 <1%
10 Hematologics Inc. $2,348,021 <1%

Top funding agencies by obligations

Rank Funding agency Obligated Share
1 Department of Veterans Affairs $1,085,256,469 84%
2 Department of Health and Human Services $81,518,831 6%
3 Department of Justice $56,291,540 4%
4 Department of Homeland Security $43,044,987 3%
5 Defense Health Agency $4,083,317 <1%
6 Department of the Army $2,556,117 <1%
7 Department of Labor $2,475,700 <1%
8 Department of the Navy $2,323,379 <1%
9 Peace Corps $658,779 <1%
10 Air Force $478,195 <1%

Obligations by fiscal year

Fiscal year Obligated
FY2027 To date $2,654,143
FY2026 $78,999,805
FY2025 $111,876,385
FY2024 $81,524,547
FY2023 $95,165,512
FY2022 $94,570,154
FY2021 $92,451,309
FY2020 $106,345,619
FY2019 $95,265,603
FY2018 $110,570,779
FY2017 $113,484,165
FY2016 $87,417,233
FY2015 $58,482,125
FY2014 $51,319,373
FY2013 $42,903,820
FY2012 $27,671,037
FY2011 $17,945,399
FY2010 $16,338,939
FY2009 $11,772,169
FY2008 $1,068,307
FY2007 $48,916
FY2006 $6,649
Show all 22

Quick answers

What is the FSS-621-II contract vehicle?

Medical Laboratory Testing and Analysis Services (FSS-621-II) is a GSA schedule run by Veterans Integrated Service Network 12 (Veterans Health Administration), awarded on October 1, 2005.

Which companies hold FSS-621-II?

57 companies hold FSS-621-II's 66 IDV awards. The latest went to Mdxhealth, Inc. on November 1, 2026. The awardees whose task orders obligated the most are Quest Diagnostics Incorporated, Laboratory Corporation Of America and Arup Laboratories Inc.

How much has been spent through FSS-621-II?

5,604 task orders have been placed under FSS-621-II, obligating $1,291,244,349. Their combined current value, with exercised options, is $1,339,700,157.

Which agencies use FSS-621-II the most?

The departments whose task orders under FSS-621-II obligated the most are Department of Veterans Affairs ($1,085,256,469), Department of Health and Human Services ($81,518,831) and Department of Justice ($56,291,540).

How much was obligated through FSS-621-II in fiscal year 2025?

Task orders under FSS-621-II obligated $111,876,385 in fiscal year 2025.

What pools does FSS-621-II have?

FSS-621-II has 16 pools, lots and SINs, including Anatomic Pathology, Clinical Drugs of Abuse and Toxicology, Microbiology and Clinical Chemistry.

On GovTribe

See this vehicle's full record

  • Every IDV award and task order
  • Funding by agency, awardee, NAICS and set-aside
  • Teaming partners on this vehicle
  • Ask GovTribe AI about this vehicle